BRIEF-Acumen Pharmaceuticals Extends Collaboration With Lonza To Add Drug Product Manufacturing Of Sabirnetug For Early Alzheimer’S Disease

Reuters
2024-09-26

Sept 26 (Reuters) - Acumen Pharmaceuticals Inc :

* ACUMEN PHARMACEUTICALS EXTENDS COLLABORATION WITH LONZA TO ADD DRUG PRODUCT MANUFACTURING OF SABIRNETUG FOR EARLY ALZHEIMER’S DISEASE

* ACUMEN PHARMACEUTICALS INC - LONZA TO PROVIDE DP MANUFACTURING SERVICES FROM VISP SITE

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10